Loading
CI
Clearday, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Walesa James, was filed 03 Jan 2023.
Insider Decl.
22
Thresholds
n/a
Buy Volume
€2M
16 ops. · all time
Sell Volume
n/a
n/a
Since the insiders bought
- +9.8%Entry US$0.87 · Close at T+365 US$0.95
- -40.0%Entry US$1.00 · Close at T+365 US$0.60
- -40.0%Entry US$1.00 · Close at T+365 US$0.60
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2022FY ended December 2022 · cache
US$0.00
Analyst consensus
Income statement
RevenueUS$12.5M
EBITDA-US$8.8M-70% margin
Net income-US$20.9M-216.5% margin
Valuation
Beta1.13
Balance sheet & cash
Total debtUS$45.1M
Free Cash Flow-US$4M
Profitability & ownership
ROA-22.3%
% institutions0.0%
Last declaration on 3 January 2023
Declarations22 total
1,776,436 shares@ US$0.675598.4% of flowCommon StockSEC:0001493152-23-000053:0
Canonical exit: 30 Mar 2023 (T+90)
157,407 sharesCommon StockSEC:0001493152-22-016747:0
Canonical exit: 8 Sept 2022 (T+90)
24,453 sharesCommon Stock, par value $0.001 per shareSEC:0001493152-22-016745:0
Canonical exit: 8 Sept 2022 (T+90)
13,033 sharesCommon Stock, par value $0.001 per shareSEC:0001493152-22-016746:0
Canonical exit: 8 Sept 2022 (T+90)
3,000 shares@ US$2.98Common StockSEC:0001493152-21-032093:1
Canonical exit: 17 Mar 2022 (T+90)
121 shares@ US$3.07Common StockSEC:0001493152-21-032093:2
Canonical exit: 20 Mar 2022 (T+90)
1,000 shares@ US$3.13215.1% of flowCommon StockSEC:0001493152-21-032093:0
Canonical exit: 16 Mar 2022 (T+90)
2,000 shares@ US$3.03Common StockSEC:0001493152-21-031779:1
Canonical exit: 15 Mar 2022 (T+90)
2,000 shares@ US$3.14330.3% of flowCommon StockSEC:0001493152-21-031779:0
Canonical exit: 14 Mar 2022 (T+90)
2,000 shares@ US$3.10Common StockSEC:0001493152-21-031470:1
Canonical exit: 13 Mar 2022 (T+90)
2,000 shares@ US$3.022129.1% of flowCommon StockSEC:0001493152-21-031470:0
Canonical exit: 10 Mar 2022 (T+90)
2,193 shares@ US$3.07Common StockSEC:0001493152-21-031010:1
Canonical exit: 9 Mar 2022 (T+90)
1,807 shares@ US$2.9325.5% of flowCommon StockSEC:0001493152-21-031010:0
Canonical exit: 8 Mar 2022 (T+90)
10,000 shares0Common StockSEC:0000895665-17-000006:0
15,000 shares0Common StockSEC:0000895665-17-000007:0
10,000 shares0Common StockSEC:0000895665-17-000005:0
200,000 shares@ US$1.69Common StockSEC:0000892712-17-000384:0
Canonical exit: 9 Jul 2017 (T+90)
2,667 shares0Common StockSEC:0000895665-17-000004:0
4,000 shares0Common StockSEC:0000895665-17-000002:0
2,667 shares0Common StockSEC:0000895665-17-000003:0
300,000 shares@ US$0.253Common StockSEC:0000892712-16-001700:0
Canonical exit: 21 Aug 2016 (T+90)
100,000 shares@ US$0.231100.0% of flowCommon StockSEC:0000892712-16-001303:0
Canonical exit: 2 May 2016 (T+90)
22 of 22 declarations
About Clearday, Inc.
One purchase dominates the record of Clearday, Inc.: James Walesa, chief executive officer, bought EUR 1,125,608 on December 30, 2022. This insider signs 11 of the 22 filings, all purchases, including EUR 5,570 on December 14, 2021. In all, 16 purchases (6 with an amount) come to EUR 1,165,197, with a median of EUR 5,461, and no sale is recorded.
LeRoy C. Kopp, a 10% owner, made 3 purchases, including EUR 21,198 in 2016. On June 10, 2022, 3 insiders bought on the same day. Lynn J. Davis, Martin A. Kaplan and Dan L. Halvorson, all directors, have 2 filings each, with no purchase or sale; the record also holds 6 grants.
Read moreShow less
Seven insiders filed between February 4, 2016 and January 3, 2023, with 9 filings in 2021, 7 in 2017 and 3 in 2022. Filings are published a median of 2 days after the trade. The Nasdaq-listed company in the Health Care sector has no filing over the last twelve months.
